Cargando…
CD8(+) tumor‐infiltrating lymphocytes within the primary tumor of patients with synchronous de novo metastatic colorectal carcinoma do not track with survival
OBJECTIVES: Tumor‐infiltrating lymphocytes (TIL), particularly CD8(+) TILs in patients with colorectal cancer (CRC), are highly prognostic in the early‐disease stages (I‐II). In metastatic disease (stage IV; mCRC), their influence is less well defined. It has presumably failed to contain tumor cells...
Autores principales: | Millen, Rosemary, Hendry, Shona, Narasimhan, Vignesh, Abbott, Rebecca, Croxford, Matthew, Gibbs, Peter, Tie, Jeanne, Wong, Hui‐Li, Jones, Ian, Kosmider, Suzanne, Byrne, David, Zalcberg, John, Fox, Stephen, Desai, Jayesh, Visvanathan, Kumar, Ramsay, Robert G, Tran, Ben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484874/ https://www.ncbi.nlm.nih.gov/pubmed/32953115 http://dx.doi.org/10.1002/cti2.1155 |
Ejemplares similares
-
Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancer
por: Millen, Rosemary, et al.
Publicado: (2016) -
Impact of Diabetes Status and Medication on Presentation, Treatment, and Outcome of Stage II Colon Cancer Patients
por: Bae, Susie, et al.
Publicado: (2015) -
The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment
por: Hendry, Shona A., et al.
Publicado: (2016) -
Biology and Clinical Implications of Fecal Occult Blood Test Screen-Detected Colorectal Cancer
por: Mendis, Shehara, et al.
Publicado: (2022) -
A mutant BRAF V600E-specific immunohistochemical assay: correlation with molecular mutation status and clinical outcome in colorectal cancer
por: Day, Fiona, et al.
Publicado: (2014)